Article
Isogenic cortical organoids enable precision targeting of APP variant-specific pathways in Alzheimer’s disease
2026-02-20
Abstract excerpt
Alzheimer’s disease (AD) lacks disease-modifying therapies, in part due to the limitations of existing disease models, which have struggled to capture the early pathogenic events leading to neuronal degeneration. Unfortunately, recent therapies targeting hallmarks of AD have proven inefficient in humans, and it is thus necessary to identify alternative targets. Here, by generating an isogenic panel of hiPSC-derive...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- f455748f-bf37-50e7-901e-c0b2bc4e1232
- DOI
- 10.64898/2026.02.19.706886
